Minerva Neurosciences Inc (NERV)
2.40
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
2.40
0.00 (0.00%)
After-Hours: 18:35
Minerva Neurosciences Cash from Financing (TTM): 19.60M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 19.60M |
September 30, 2023 | 19.60M |
June 30, 2023 | 19.69M |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 60.00M |
September 30, 2021 | 60.00M |
June 30, 2021 | 67.14M |
March 31, 2021 | 72.44M |
December 31, 2020 | 13.24M |
September 30, 2020 | 13.24M |
June 30, 2020 | 6.103M |
March 31, 2020 | 0.7976M |
December 31, 2019 | 0.525M |
September 30, 2019 | 0.6901M |
June 30, 2019 | -0.2171M |
March 31, 2019 | -1.530M |
December 31, 2018 | -3.345M |
Date | Value |
---|---|
September 30, 2018 | -4.777M |
June 30, 2018 | 37.10M |
March 31, 2018 | 37.44M |
December 31, 2017 | 47.17M |
September 30, 2017 | 48.49M |
June 30, 2017 | 6.985M |
March 31, 2017 | 66.46M |
December 31, 2016 | 76.57M |
September 30, 2016 | 76.51M |
June 30, 2016 | 77.05M |
March 31, 2016 | 18.31M |
December 31, 2015 | 38.34M |
September 30, 2015 | 38.31M |
June 30, 2015 | 88.66M |
March 31, 2015 | 89.78M |
December 31, 2014 | 51.60M |
September 30, 2014 | 53.56M |
June 30, 2014 | 3.209M |
March 31, 2014 | 4.176M |
December 31, 2013 | 3.782M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.2171M
Minimum
Jun 2019
72.44M
Maximum
Mar 2021
18.57M
Average
6.103M
Median
Jun 2020
Cash from Financing (TTM) Benchmarks
Viking Therapeutics Inc | 873.23M |
Janux Therapeutics Inc | 59.55M |
ACADIA Pharmaceuticals Inc | 25.13M |
Karyopharm Therapeutics Inc | 1.124M |
Calidi Biotherapeutics Inc | -- |